Related Experiment Video
Updated: May 21, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Economic impact of services for first-episode psychosis: a decision model approach
Paul McCrone1, Martin Knapp, Sujith Dhanasiri
1Institute of Psychiatry, King's College London, London, UK. paul.mccrone@kcl.ac.uk
Aim:
To assess the impact of early intervention (EI) services on service costs for people with first-episode psychosis.
Methods:
A decision model was constructed to map the care pathways following input from EI services and from standard care. A Markov process was used to run the model over 18 2-month cycles. Probabilities and costs for the model of admissions, readmissions and use of community services were obtained from the literature, routine sources and expert opinion. One-way and probabilistic sensitivity analyses were conducted to address uncertainty around the parameter estimates.
Results:
The model estimated 1 year costs to be £9422 for EI and £14,394 for standard care. The respective figures over 3 years were £26,568 and £40,816. One-way sensitivity analyses revealed that the results were robust to changes in most parameters with the exception of the readmission rate. A relatively small decrease in the readmission rate for standard care patients would eliminate the cost saving. The probabilistic sensitivity analyses also showed that the results were robust to parameter changes.
Conclusions:
This study suggests cost savings associated with EI. However, caution is required as the model is relatively simple and relies on a number of assumptions.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
